Editorial: testing for Epstein-Barr virus and treating autoimmune hepatitis-still a long way to go!

Affiliations

¹ Division of Paediatric Gastroenterology, Department of Paediatrics, All India Institute of Medical Sciences, Rishikesh, India.
² Department of Paediatric Gastroenterology, Sanjay Gandhi Postgraduate of Medical Sciences, Lucknow, India.

Editorial

Rishi Bolia et al. Aliment Pharmacol Ther. 2022 Feb.

. 2022 Feb;55(3):364-365.

doi: 10.1111/apt.16751.

¹ Division of Paediatric Gastroenterology, Department of Paediatrics, All India Institute of Medical Sciences, Rishikesh, India.
² Department of Paediatric Gastroenterology, Sanjay Gandhi Postgraduate of Medical Sciences, Lucknow, India.

No abstract available

Comment in

Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Authors' reply.
Nayagam JS, Heneghan MA, Samyn M, Joshi D. Nayagam JS, et al. Aliment Pharmacol Ther. 2022 Feb;55(3):366-367. doi: 10.1111/apt.16759. Aliment Pharmacol Ther. 2022. PMID: 35040167 No abstract available.

Epstein-Barr virus status and immunosuppression use in paediatric autoimmune liver disease.
Nayagam JS, Heneghan MA, Samyn M, Joshi D. Nayagam JS, et al. Aliment Pharmacol Ther. 2022 Feb;55(4):455-463. doi: 10.1111/apt.16708. Epub 2021 Nov 18. Aliment Pharmacol Ther. 2022. PMID: 34796537

1. Hyams JS, Dubinsky MC, Baldassano RN, et al. Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease. Gastroenterology. 2017;152:1901-1914.e3.
1. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617-1625.
1. Joosse ME, Aardoom MA, Kemos P, et al. Paediatric IBD Porto group of ESPGHAN. Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN. Aliment Pharmacol Ther. 2018;48:523-537.
1. Jensen MD, Jepsen P, Vilstrup H, Grønbaek L. Increased cancer risk in autoimmune hepatitis: a Danish nationwide cohort study. Am J Gastroenterol. 2021. doi: 10.14309/ajg.0000000000001525. Online ahead of print.
1. Hoeroldt BS, Gleeson D, Shephard K, et al. PTU-077 increased long-term cancer risk in autoimmune hepatitis (AIH): relation to immunosuppressive drug treatment. Gut 2016;65:A91.